Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
ELAN Elanco Animal Health Inc
- Stocks
- Healthcare
- NYSE: ELAN
Price (delayed)
$13.44
Market cap
$6.67B
P/E Ratio
17.68
Dividend/share
N/A
EPS
$0.76
Enterprise value
$10.58B
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company,
Highlights
The company's EPS has surged by 129% YoY and by 12% QoQ
Elanco Animal Health's net income has soared by 129% YoY and by 10% from the previous quarter
Key stats
What are the main financial stats of ELAN
Market
Valuations
Earnings
Shares outstanding
496.65M
Market cap
$6.67B
Enterprise value
$10.58B
Price to earnings (P/E)
17.68
Price to book (P/B)
1.05
Price to sales (P/S)
1.5
EV/EBIT
14.21
EV/EBITDA
7.55
EV/Sales
2.39
Revenue
$4.43B
Gross profit
$2.43B
Operating income
$117M
Net income
$373M
EBIT
$745M
EBITDA
$1.4B
Free cash flow
$347M
Per share
Balance sheet
Liquidity
EPS
$0.76
EPS diluted
$0.74
Free cash flow per share
$0.7
Book value per share
$12.84
Revenue per share
$8.94
TBVPS
$9.69
Total assets
$12.94B
Total liabilities
$6.59B
Debt
$4.4B
Equity
$6.35B
Working capital
$2.17B
Debt to equity
0.69
Current ratio
2.71
Quick ratio
1.22
Net debt/EBITDA
2.79
Margins
Efficiency
Dividend
EBITDA margin
31.7%
Gross margin
54.9%
Net margin
8.4%
Operating margin
2.6%
Return on assets
2.8%
Return on equity
6%
Return on invested capital
9.7%
Return on capital employed
6.4%
Return on sales
16.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ELAN stock price
How has the Elanco Animal Health stock price performed over time
Intraday
-0.15%
1 week
0.3%
1 month
37.85%
1 year
-26.15%
YTD
10.98%
QTD
28%
Financial performance
How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.43B
Gross profit
$2.43B
Operating income
$117M
Net income
$373M
Gross margin
54.9%
Net margin
8.4%
Elanco Animal Health's net income has soared by 129% YoY and by 10% from the previous quarter
The net margin has soared by 128% year-on-year and by 11% since the previous quarter
Elanco Animal Health's operating income has soared by 112% YoY and by 41% from the previous quarter
The company's operating margin has surged by 111% YoY and by 37% QoQ
Price vs fundamentals
How does ELAN's price correlate with its fundamentals
Growth
What is Elanco Animal Health's growth rate over time
Valuation
What is Elanco Animal Health stock price valuation
P/E
17.68
P/B
1.05
P/S
1.5
EV/EBIT
14.21
EV/EBITDA
7.55
EV/Sales
2.39
The company's EPS has surged by 129% YoY and by 12% QoQ
The price to book (P/B) is 19% lower than the 5-year quarterly average of 1.3 but 5% higher than the last 4 quarters average of 1.0
ELAN's equity is up by 4.9% YoY and by 4.2% from the previous quarter
ELAN's P/S is 35% below its 5-year quarterly average of 2.3 but 7% above its last 4 quarters average of 1.4
Efficiency
How efficient is Elanco Animal Health business performance
Elanco Animal Health's ROIC has soared by 189% YoY and by 10% from the previous quarter
The company's return on sales has surged by 172% YoY and by 3.1% QoQ
The company's return on assets has surged by 131% YoY and by 12% QoQ
Elanco Animal Health's ROE has soared by 130% YoY and by 9% from the previous quarter
Dividends
What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ELAN.
Financial health
How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 96% higher than its total liabilities
Elanco Animal Health's current ratio has decreased by 18% YoY but it has increased by 11% from the previous quarter
The quick ratio has grown by 18% from the previous quarter and by 5% YoY
The debt is 31% smaller than the equity
The debt to equity has declined by 27% year-on-year and by 2.8% since the previous quarter
The debt is down by 24% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.